Stopping and slowing manual and spoken responses: Similar oscillatory signatures recorded from the subthalamic nucleus.

Brain Lang

Krembil Research Institute, Toronto, ON, Canada; Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada. Electronic address:

Published: January 2018

Response control in the forms of stopping and slowing responses is thought to be implemented by a frontal-subcortical network, which includes the subthalamic nucleus (STN). For manual control, stopping is linked to STN beta (13-30 Hz) and slowing responses are linked to lower frequencies (<12 Hz). Whether similar STN oscillatory activities are associated with the control of spoken responses is not clear. We studied 16 patients with STN LFP recordings during manual and vocal stop signal tasks in two experiments. We found increased beta activities for stopping spoken responses, similar to manual stopping. However, unlike manual stopping, stopping spoken responses elicited a right-lateralized beta power increase, which may be related to previously reported hyperactivity of right-sided motor control regions in stuttering. We additionally studied STN power changes associated with slowing responses in the same stop-signal tasks by comparing slower vs. faster go trials. Now, rather than beta, there was an alpha power increase after Go cues, which remained elevated only in slower Go trials in both the vocal and manual tasks. These data show that different types of response control are generalizable across effectors and relate to different frequencies recorded from the STN.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bandl.2017.10.009DOI Listing

Publication Analysis

Top Keywords

stopping slowing
8
subthalamic nucleus
8
slowing responses
8
slowing manual
4
manual spoken
4
spoken responses
4
responses oscillatory
4
oscillatory signatures
4
signatures recorded
4
recorded subthalamic
4

Similar Publications

Unlabelled: The Alzheimer's disease (AD) research field has entered a new era, where our fundamental understanding of the pathophysiology of AD and advances in biomarkers have not only allowed for earlier, timely, and accurate detection and diagnosis of the disease, but that amyloid removal has been shown to be associated with signals of slowing cognitive and functional decline. Although recent FDA-approved amyloid plaque-lowering monoclonal antibody therapies have shifted the trajectory of AD, additional treatment options will be key to further slowing clinical decline or stopping disease progression. Thus, new and emerging therapies for AD have created an evolving therapeutic landscape.

View Article and Find Full Text PDF
Article Synopsis
  • The number of people diagnosed with Parkinson's disease (PD) may surpass 10 million globally by 2040, raising concerns about its unclear causes.
  • Recent studies have explored the gut-brain axis, suggesting that gut bacteria and gut dysbiosis may influence PD by contributing to inflammation and accelerating nerve damage.
  • Research also indicates that probiotics could potentially treat PD by restoring gut balance, increasing brain dopamine levels, and reducing neurodegeneration through mechanisms involving oxidative stress and α-synuclein aggregation.
View Article and Find Full Text PDF

Heavy oils, particularly in cold water, spread slowly and eventually stop at a certain film thickness, known as the terminal film thickness. A few studies have specifically addressed the conditions and physical mechanisms that terminate the spreading process. However, traditional models for oil spreading on calm water do not predict this behavior, which may be due to a net negative surface tension effect.

View Article and Find Full Text PDF

A novel sustained-release agent based on disulfide-induced recombinant collagen hydrogels for the prevention and treatment of infections.

Microbiol Spectr

December 2024

Ministry of Education Key Laboratory of Industrial Biotechnology, School of Biotechnology, Jiangnan University, Wuxi, China.

Schistosomiasis is commonly managed using the praziquantel, but it is only effective against adult worms and duration of action is short. Liver fibrosis will worsen if eggs are still present after stopping treatment. Therefore, this study aimed to develop a sustained drug release system for effectively preventing and treating schistosomiasis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!